Non‐Engineered Physiologically Modulated Nanovesicles Augment Antitumor Immune Responses via Dual‐Pathway T Cell Activation
Advanced Materials · 2026-06 · 38 (32)
DOI: 10.1002/adma.73231 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 01.05.2026. Verfasst von Xiaoyuan Fan und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Lymphocyte Activation, Nanovaccines, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Liaoning Province Applied Basic Research Program, Liaoning Revitalization Talents Program.
Abstract (Originalsprache)
The therapeutic efficacy of cancer vaccines is critically contingent upon CD8 + T cell‐mediated antitumor immunity, but the effectiveness is hindered due to insufficient T cell activation. Inspired by the close interplay between cellular physiological states and immunoregulatory functions, we propose ASCENT, a nanovaccine platform integrating nanovesicles derived from activated platelets and senescent tumor cells to naturally co‐present antigens and co‐stimulatory molecules, thereby enabling dual‐pathway T cell activation. Specifically, senescent tumor cells promote antigen presentation via upregulated major histocompatibility complex‐I (MHC‐I) molecules, whereas activated platelets increase the surface expression of CD40L and OX40L, thereby enhancing immune activation. Thus, without genetic or chemical engineering, ASCENT can effectively stimulate CD8 + T cells through both antigen self‐presentation and dendritic cell‐mediated antigen presentation, ultimately eliciting robust immune responses. This non‐engineered, physiologically modulated nanovaccine exhibits broad‐spectrum antitumor activity while simultaneously inducing durable systemic immune memory to effectively suppress tumor recurrence and metastasis. Overall, the ASCENT nanovaccine provides new perspectives on rational vaccine design, emphasizing the importance of engaging both direct and indirect T cell activation in reinforcing cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China.
- Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, China.
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China.
- Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang, China.
ORCID-Profile: Lianwen Qi, Zhonggui He, Jin Sun, Kaiyuan Wang
Förderung
- National Natural Science Foundation of China
- Liaoning Province Applied Basic Research Program
- Liaoning Revitalization Talents Program
- Prospective Basic research project of 2024 Scientific Research Project of Liaoning Department of Education
Zitieren
APA
Fan, X., Liu, F., You, Q., Wang, Y., Du, L., Zou, X., Sun, F., Qi, L., He, Z., Sun, J., Wang, S., Sang, L., & Wang, K. (2026). Non‐Engineered Physiologically Modulated Nanovesicles Augment Antitumor Immune Responses via Dual‐Pathway T Cell Activation. Advanced Materials, 38(32). https://doi.org/10.1002/adma.73231
Vancouver
Fan X, Liu F, You Q, Wang Y, Du L, Zou X, et al. Non‐Engineered Physiologically Modulated Nanovesicles Augment Antitumor Immune Responses via Dual‐Pathway T Cell Activation. Advanced Materials. 2026;38(32). doi:10.1002/adma.73231
BibTeX
@article{Fan2026,
author = {Fan, Xiaoyuan and Liu, Fengxiang and You, Qing and Wang, Yiyang and Du, Lili and Zou, Xinpeng and Sun, Fei and Qi, Lianwen and He, Zhonggui and Sun, Jin and Wang, Shujun and Sang, Liang and Wang, Kaiyuan},
title = {Non‐Engineered Physiologically Modulated Nanovesicles Augment Antitumor Immune Responses via Dual‐Pathway T Cell Activation},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {32},
doi = {10.1002/adma.73231}
}
EUVIMED